VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination

Completed · Not applicable

Conditions studied: Immunization; Infection, Pregnancy Related, COVID-19

In brief

COVID-19 infection during pregnancy is associated with increased risk of pre-eclampsia, preterm birth and stillbirth. Pregnant people with COVID-19 have a higher rate of ICU admission and intubation than those who are not pregnant. COVID-19 vaccine is recommended before pregnancy and during pregnancy to decrease these risks. Despite the benefits of COVID-19 vaccination, only 71% of pregnant women were vaccinated for COVID-19 as of June 2022 (most prior to pregnancy), with a much lower rate of 58% among non-Hispanic Black women. An effective intervention is needed to improve COVID vaccination rates for pregnant people overall. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of increasing maternal COVID-19 vaccination rates.

Key facts

Study ID

NCT05570630

Run by

University of Rochester

People needed

6911

Starts

2022-10-21

Expected to finish

2024-07-31

Last updated by the study team

2025-09-04

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patient criteria:
• Sex is female
• Pregnant
• Identified as being eligible for COVID-19 vaccine
• Practice personnel criteria:
• Provider, nurse or staff currently affiliated with (employed with) the participating OB/GYN sites

You may not qualify if…

• None

Where it is running

• University of Rochester Medical Center (URMC) — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.